Phase 4 Portal Hypertension Clinical Trials
5 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–5 of 5 trials
Recruiting
Phase 4
Apixaban-PK Trial: Preventing Portal Hypertension Complications in Cirrhosis
CirrhosisAscitesPortal Vein Thrombosis+3 more
Asian Institute Of Medical Sciences220 enrolled1 locationNCT07521332
Recruiting
Phase 4
Optimizing Portal Hypertension With TIPS and Interval Metabolic Surgery for Advanced Liver Disease
Portal Hypertension Related to CirrhosisLiver CirrhosesTIPS+1 more
The Cleveland Clinic70 enrolled1 locationNCT07058155
Recruiting
Phase 4
Non-selective Beta-blocker in Compensated Advanced Chronic Liver Disease
Advanced Chronic Liver DiseasePortal HypertensionHepatic Decompensation
Chinese University of Hong Kong474 enrolled1 locationNCT06449339
Recruiting
Phase 4
Prevention of Post-TIPS Hepatic Encephalopathy by Administration of Rifaximin and Lactulose
Liver DiseasesCirrhosis, LiverPortal Hypertension+2 more
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)238 enrolled6 locationsNCT04073290
Recruiting
Phase 4
Beta-blockers or Placebo for Primary Prophylaxis (BOPPP) of Oesophageal Varices Trial.
Cirrhosis, LiverPortal HypertensionVariceal Hemorrhage+1 more
King's College Hospital NHS Trust1,200 enrolled1 locationNCT05872698